Jieying Liu Selected Research

Glycated Hemoglobin (Glycosylated Hemoglobin)

8/2021	A Clinical Prediction Model to Distinguish Maturity-Onset Diabetes of the Young From Type 1 and Type 2 Diabetes in the Chinese Population.
1/2019	Birthweight correlates with later metabolic abnormalities in Chinese patients with maturity-onset diabetes of the young type 2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jieying Liu Research Topics

Disease

12	Neoplasms (Cancer) 07/2021 - 01/2013
2	Insulin Resistance 01/2022 - 08/2019
2	Type 2 Diabetes Mellitus (MODY) 08/2021 - 01/2019
2	Familial Partial Lipodystrophy (Dunnigan Syndrome) 01/2020 - 01/2020
2	Type 2 Maturity-Onset Diabetes of the Young 08/2019 - 01/2019
2	Prostatic Neoplasms (Prostate Cancer) 12/2018 - 01/2018
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2017 - 05/2017
2	Breast Neoplasms (Breast Cancer) 02/2015 - 02/2014
1	Headache (Headaches) 04/2022
1	Metabolic Diseases (Metabolic Disease) 01/2022
1	Overnutrition 01/2022
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 01/2022
1	Liver Cell Adenoma (Hepatocellular Adenoma) 08/2021
1	Diabetes Mellitus 04/2021
1	Hypoglycemia (Reactive Hypoglycemia) 04/2021
1	Diabetes Complications 04/2021
1	Cicatrix (Scar) 01/2020
1	Wounds and Injuries (Trauma) 01/2020
1	Type 3 Maturity-Onset Diabetes of the Young 08/2019
1	Obesity 01/2019
1	Body Weight (Weight, Body) 01/2019
1	Mason-Type Diabetes 01/2019
1	Birth Weight (Birth Weights) 01/2019
1	Carcinogenesis 01/2018
1	Lung Neoplasms (Lung Cancer) 05/2017
1	Thyroid Neoplasms (Thyroid Cancer) 10/2016
1	Follicular Adenocarcinoma 10/2016
1	Inflammation (Inflammations) 07/2015
1	Esophageal Neoplasms (Esophageal Cancer) 01/2015
1	Head and Neck Neoplasms (Head and Neck Cancer) 05/2012
1	Dehydration (Water Stress) 05/2012
1	Opportunistic Infections (Opportunistic Infection) 04/2009
1	Infections 04/2009

Drug/Important Bio-Agent (IBA)

5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2019
4	Paclitaxel (Taxol)FDA LinkGeneric 12/2018 - 11/2013
4	Pharmaceutical PreparationsIBA 12/2018 - 11/2013
4	MicellesIBA 02/2015 - 01/2013
3	Insulin (Novolin)FDA Link 04/2021 - 01/2019
2	Nonesterified Fatty Acids (NEFA)IBA 01/2022 - 08/2019
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 08/2021 - 01/2019
2	GlucokinaseIBA 08/2021 - 01/2019
2	Triglycerides (Triacylglycerol)IBA 08/2021 - 08/2019
2	C-PeptideIBA 08/2021 - 08/2019
2	C-Reactive ProteinIBA 08/2021 - 08/2019
2	Lamin Type A (Lamin A)IBA 01/2020 - 01/2020
2	GenisteinIBA 08/2019 - 01/2019
2	LDL CholesterolIBA 08/2019 - 01/2019
2	CholesterolIBA 08/2019 - 01/2019
2	LipidsIBA 08/2019 - 08/2019
2	oxidized low density lipoproteinIBA 08/2019 - 01/2019
2	CurcuminIBA 02/2014 - 01/2013
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 04/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 04/2022
1	Nimodipine (Modus)FDA LinkGeneric 04/2022
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 04/2022
1	SteroidsIBA 04/2022
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 04/2022
1	Betaine (C.B.B.)FDA Link 01/2022
1	Hepatocyte Nuclear Factor 1IBA 08/2021
1	AntibodiesIBA 08/2021
1	Choline (Choline Chloride)IBA 07/2021
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 07/2021
1	Glycerophospholipids (Phosphoglycerides)IBA 07/2021
1	Proteins (Proteins, Gene)FDA Link 04/2021
1	CarbohydratesIBA 04/2021
1	Blood Glucose (Blood Sugar)IBA 08/2019
1	AlbuminsIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Trefoil FactorsIBA 01/2018
1	CateninsIBA 09/2017
1	MicroRNAs (MicroRNA)IBA 09/2017
1	Interleukin-6 (Interleukin 6)IBA 05/2017
1	Diethylhexyl Phthalate (DEHP)IBA 05/2017
1	phthalic acid (phthalate)IBA 05/2017
1	RacivirIBA 10/2016
1	Sirolimus (Rapamycin)FDA Link 02/2015
1	Indicators and Reagents (Reagents)IBA 02/2015
1	Fluorouracil (Carac)FDA LinkGeneric 01/2015
1	Angiogenesis InhibitorsIBA 02/2014
1	dilactideIBA 11/2013
1	Dosage Forms (Dosage Form)IBA 11/2013
1	caprolactoneIBA 11/2013
1	Fluorescein-5-isothiocyanate (FITC)IBA 09/2013
1	Lipid NanoparticlesIBA 01/2013
1	CyclodextrinsIBA 01/2013
1	Liposomes (Liposome)IBA 01/2013
1	Mannitol (Osmitrol)FDA LinkGeneric 05/2012
1	Inulin FDA Link 05/2012
1	Excipients (Suspending Agents)IBA 05/2012
1	Sucrose (Saccharose)IBA 05/2012
1	EndostatinsIBA 05/2012
1	Folic Acid AntagonistsIBA 04/2009
1	Trimethoprim (Proloprim)FDA LinkGeneric 04/2009

Therapy/Procedure

6	Therapeutics 04/2021 - 01/2013
3	Stents 12/2018 - 01/2015
2	Drug Therapy (Chemotherapy) 12/2018 - 07/2015
1	Glycemic Control 04/2021
1	Transplantation 01/2020
1	Immunotherapy 05/2017